Stockholders' Equity - Schedule of Warrants (Detail) - Common Stock Warrants [Member] |
6 Months Ended |
---|---|
Dec. 31, 2021
$ / shares
shares
| |
Balance – June 30, 2021 | shares | 6,974,000 |
Issuance of 2022 Investor Warrants | shares | 12,000,000 |
Issuance of PFW | shares | 4,800,000 |
Issuance of 2022 Agent Warrants | shares | 600,000 |
Exercise of PFW | shares | (4,800,000) |
Exercise of 2020 Investor Warrants | shares | (69,000) |
Expiry of Adgero replacement warrants | shares | (353,000) |
Balance – December 31, 2021 | shares | 19,152,000 |
Beginning balance | $ / shares | $ 3.34 |
Issuance of 2022 Investor Warrants | $ / shares | 1.25 |
Issuance of PFW | $ / shares | 0.001 |
Issuance of 2022 Agent Warrants | $ / shares | 1.5625 |
Exercise of PFW | $ / shares | 0.001 |
Stock option exercise price | $ / shares | 1.00 |
Expiry of Adgero replacement warrants | $ / shares | 3.18 |
Ending balance | $ / shares | $ 1.99 |
X | ||||||||||
- Definition Exercise of 2020 investor warrants. No definition available.
|
X | ||||||||||
- Definition Exercise of PFW. No definition available.
|
X | ||||||||||
- Definition Issuance of 2022 agent warrants. No definition available.
|
X | ||||||||||
- Definition Issuance of 2022 investor warrants. No definition available.
|
X | ||||||||||
- Definition Issuance of PFW. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangements by Share Based Payment Award Options Exercise of Pre Funded Warrants Weighted Average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangements by Share Based Payment Award Options Expiry of Warrants Issued for Services Weighted Average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Issuance 2022 agent warrants weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Issuance of investor warrants weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Issuance PWF weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
X | ||||||||||
- Details
|